SecBot SecBot

PTPI

Petros Pharmaceuticals, Inc.
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001815903 Biotech & Drug Discovery
$0.001900 −0.00 (−5.00%)
Oct 27 4:00 PM ET · prev $0.002000
1 year
−90.5%
from $0.0200 · Oct 27
30 days
−52.5%
from $0.004000
52-week range
$0.001900–0.0230
at the low
Avg volume 20D
169.7K
Oct 1 spike 1.18M
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q1 2025 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest BEARISH Petros Pharmaceuticals has entered into a General Assignment for the Benefit of Creditors (ABC) under…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q1 2025: 3 added (0 new), 0 trimmed or exited.

  • TrendDOWNTREND

    54% below its 50-day average. New closing low $0.001900 on Oct 27.

Who's buying

13F· Q1 2025
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED119,072$8.2K
GEODE CAPITAL MANAGEMENT, LLCDOUBLED108,180$7.5K
MORGAN STANLEYDOUBLED704$48.00
UBS Group AGTRIM12,992$5.1K
NATIONAL BANK OF CANADA /FI/TRIM200$79.00
BANK OF AMERICA CORP /DE/ADD72$26.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Dec 2023
Recent actions
DateFirmActionRating
Dec 8, 2023Maxim Group
INITIATE
INITIATEBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jun 5, 2026
WALKER WAYNE REMELL
Director
AWARD375,000 sh
Jun 5, 2026
Boctor Fady
See Remarks
AWARD375,000 sh
Jun 5, 2026
Silverman Joshua
Director
AWARD4,375,000 sh
Jun 5, 2026
Bernstein Bruce
Director
AWARD1,875,000 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 SEC
Petros Pharmaceuticals has entered into a General Assignment for the Benefit of Creditors (ABC) under California law…
8-K — Impact 9/10
Jun 25, 2026 SEC
Robert Weinstein filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing 636,004 shares of…
3 — Impact 2/10
Jun 5, 2026 Insider
WALKER WAYNE REMELL was granted 375,000 shares
Director
Jun 5, 2026 Insider
Boctor Fady was granted 375,000 shares
See Remarks
Jun 5, 2026 Insider
Silverman Joshua was granted 4,375,000 shares
Director
Mar 31, 2025 Inst.
UBS Group AG — DOUBLED
119,072 shares ($8.2K)
Mar 31, 2025 Inst.
GEODE CAPITAL MANAGEMENT, LLC — DOUBLED
108,180 shares ($7.5K)

SecBot reports

2 filings · 0 bullish · 1 bearish · 1 neutral
All PTPI filing & press-release reports (2)